
Newpong, a specialized ultrasound-based medical device company, will participate in the 41st Korea International Medical & Hospital Equipment Show (KIMES 2026), taking place March 19–22, 2026, at COEX in Seoul. At Booth A713, the company will present its complete product portfolio, reinforcing its position as a global leader in ultrasound energy platforms while unveiling its strategic expansion into the premium home beauty device segment.
Now in its 41st edition, KIMES stands as one of Asia’s most influential international medical exhibitions, bringing together global manufacturers, distributors, and healthcare professionals. At this year’s exhibition, Newpong aims to further solidify its identity as a B2B-focused medical solutions provider built upon advanced ultrasound energy control technology.
■Proven Ultrasound Platform Across Clinical Applications
Since its inception, Newpong has centered its growth strategy on B2B medical markets, supplying hospitals and clinics with precision-engineered ultrasound systems. Leveraging proprietary energy control technology and stable output algorithms, the company has developed a versatile ultrasound platform applicable across surgical, aesthetic, and therapeutic fields.
The product lineup featured at KIMES 2026 includes:
Lincurve Pro – The world’s first curved HIFU system equipped with a patented concave cartridge
LSSA – A minimally invasive ultrasound-assisted lipolysis device featuring the world’s smallest 0.9 mm diameter probe
Sonocare – Therapeutic ultrasound devices for pain relief and wound healing
This diversified portfolio reflects Newpong’s evolution from single-device manufacturing to a comprehensive ultrasound-based medical solution provider.

■Lincurve : Strategic Expansion from B2B to B2C
Among the highlights of this year’s exhibition is Lincurve, Newpong’s home-use HIFU device derived from the technological foundation of its clinical system, Lincurve Pro.
While Newpong remains fundamentally a B2B medical device company, Lincurve represents a strategic extension of its validated clinical energy delivery mechanism into the premium home beauty device market. Rather than a conventional consumer beauty gadget, the device is positioned as a medical-technology-derived home solution engineered with professional-grade DNA. The device adopts the same Concave Technology™ applied to Lincurve Pro — the world’s first curved HIFU system — enabling natural conformity to the facial contour and more uniform, stable ultrasound energy delivery.
Through Lincurve, Newpong aims to enter the rapidly expanding global home aesthetic device market while maintaining its identity as a technology-driven medical brand.
■Accelerating Global Distribution Partnerships
Newpong has already established distribution partnerships across multiple international markets. During KIMES 2026, the company plans to hold strategic meetings with existing partners while actively engaging new overseas buyers, particularly those exploring high-performance home beauty devices backed by medical-grade technologies.
As global demand for advanced aesthetic and therapeutic solutions continues to rise, industry observers anticipate strong buyer interest in Newpong’s ultrasound platform technology and its scalable applications.
A company representative stated, “Newpong’s true competitive strength lies not in a single product, but in our comprehensive ultrasound energy control technology. Through KIMES 2026, we intend to further establish our global leadership in ultrasound-based medical solutions.”
Visitors can experience Newpong’s complete product lineup, including the newly introduced Lincurve, at Booth A713 at COEX.
■KIMES 2026 as a Launchpad for Global Growth
KIMES 2026 provides a strategic platform for international expansion and cross-border collaboration in the medical device industry. Newpong will use this opportunity to reinforce its position as a B2B-focused ultrasound technology leader while demonstrating how its platform strategy enables expansion from clinical environments into consumer markets